Netherlands· NL-9d6df37aaf22
Buvidal 128 mg oplossing voor injectie met verlengde afgifte
A buprenorphine product containing buprenorfine, registered in Netherlands by Camurus AB. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Buprenorphine is registered in 13 of 19 countries.
Countries holding a registration under ATC N07BC01 (buprenorphine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Buprenorphine · ATC N07BC01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of buprenorphine costs, country by country.
Normalised to the WHO defined daily dose (1.6 mg), the median price runs from $1.13 in Switzerland to $4.31 in Spain — a ×3.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Buprenorphine · price per daily dose (1.6 mg)
USD · FX 28 Sept 2026
- ES Spain$4.31
- IT Italy$3.30
- CH Switzerland$1.13
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BUPRENORFINE
- Manufacturer
- Camurus AB
- Country
- Netherlands (NL)
- ATC code
- N07BC01
- ATC class
- Buprenorphine
- Defined daily dose
- 1.6 mg, Implantat
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/18/1336
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
376 interactions on record for buprenorphine.
Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buprenorphine · interactions on record
376 records
- 59 severe
- 253 moderate
- 2 minor
- 52 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- DronabinolA04AD10severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buprenorphine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceBUVIDAL 128 mg, solution injectable à libération prolongéeCAMURUS (SUEDE)
- IrelandBuvidal 128 mg Prolonged-release solution for injectionCamurus AB
- CzechiaADDNOKI-GEN, LDA, Caparica
- United KingdomBunov 10micrograms/hour transdermal patchesGlenmark Pharmaceuticals Europe Ltd
- United StatesBELBUCABioDelivery Sciences International Inc
- SwedenBuprefarm 10 mikrogram/timme DepotplåsterOrifarm Generics A/S
- FinlandBupaq Multidose vetVetViva Richter GmbH
- GermanyAcimaphinLuye Pharma Ag
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Astec, Bupensan
- Belgium · Temgesic, Transtec
- Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
- Cyprus · Buvera
- Czechia · Addnok, Buprenorfin Stada
- Germany · Acimaphin, Acinorphin
- Denmark · Buprefarm, Bupremyl
- Estonia · Buprenorphine G.L. Pharma
- Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
- Finland · Buprefarm, Bupremyl
- France · Bupensan, Buprenorphine Arrow
- United Kingdom (Northern Ireland) · Addnok, Bunov
- Greece · Buprenal, Buvera
- Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
- Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
- Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
- Italy · Buprenorfina Molteni, Buprenorfina Sandoz
- Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
- Luxembourg · Temgesic, Temgesic Sublingualis
- Latvia · Buprenorphine G.L. Pharma
- Malta · Buprenorphine Aspire Pharma (Malta), Natzon
- Norway · Bugnanto, Buprefarm
- Poland · Bunondol, Bunorfin
- Portugal · Buprenorfina, Buprenorfina Aurovitas
- Sweden · Buprefarm, Buprenorfin Actavis
- Slovenia · Addnok, Buprenorfin Alkaloid-Int
- Slovakia · Bupretec, Noprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd0f5dc4-2d41-4c7f-9853-0c2522aa13f4 GET /v1/drugs/fd0f5dc4-2d41-4c7f-9853-0c2522aa13f4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/buvidal-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Buprenorphine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp121733",
"excipients": [
"FOSFATIDYLCHOLINE, SOYA",
"GLYCERYLDIOLEAAT",
"N-METHYLPYRROLIDON",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"BUPRENORFINE"
],
"leaflet_url": null,
"authorised_at": "2018/11/20",
"procedure_number": "EMEA/H/C/004651",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/18/1336",
"additional_monitoring": "N"
}See everything about buprenorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.